Wells Fargo & Company MN boosted its stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 22.2% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 31,918 shares of the company's stock after purchasing an additional 5,809 shares during the period. Wells Fargo & Company MN owned about 0.18% of Addus HomeCare worth $4,001,000 at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in the company. Summit Place Financial Advisors LLC boosted its holdings in Addus HomeCare by 0.9% in the fourth quarter. Summit Place Financial Advisors LLC now owns 9,410 shares of the company's stock valued at $1,180,000 after purchasing an additional 80 shares in the last quarter. Janney Montgomery Scott LLC raised its stake in Addus HomeCare by 0.9% during the 4th quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company's stock worth $1,340,000 after acquiring an additional 91 shares in the last quarter. Alliancebernstein L.P. lifted its position in Addus HomeCare by 0.5% in the fourth quarter. Alliancebernstein L.P. now owns 19,661 shares of the company's stock valued at $2,465,000 after acquiring an additional 91 shares during the last quarter. Parkside Financial Bank & Trust boosted its stake in Addus HomeCare by 38.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after acquiring an additional 148 shares in the last quarter. Finally, Exchange Traded Concepts LLC boosted its stake in Addus HomeCare by 2.6% in the fourth quarter. Exchange Traded Concepts LLC now owns 5,923 shares of the company's stock valued at $742,000 after acquiring an additional 150 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.
Addus HomeCare Stock Up 0.6 %
Shares of ADUS traded up $0.63 on Friday, hitting $100.17. 51,943 shares of the stock traded hands, compared to its average volume of 162,805. The firm has a market capitalization of $1.82 billion, a P/E ratio of 22.90, a P/E/G ratio of 1.41 and a beta of 0.93. Addus HomeCare Co. has a 1 year low of $88.96 and a 1 year high of $136.72. The stock's 50 day moving average is $98.20 and its two-hundred day moving average is $116.35.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $297.14 million during the quarter, compared to analysts' expectations of $291.04 million. Research analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current year.
Analyst Upgrades and Downgrades
ADUS has been the topic of a number of recent research reports. Oppenheimer lifted their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Macquarie reiterated an "outperform" rating and issued a $129.00 target price on shares of Addus HomeCare in a research note on Thursday, February 27th. JMP Securities restated a "market outperform" rating and set a $150.00 price target on shares of Addus HomeCare in a research note on Tuesday. Stephens reiterated an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a research report on Wednesday, March 12th. Finally, StockNews.com downgraded Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. One analyst has rated the stock with a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $139.00.
Check Out Our Latest Report on ADUS
Addus HomeCare Company Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Articles

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.